Where patients are unable to achieve glycemic control early in pregnancy and develop GDM or have existing diabetes before pregnancy, a targeted combination of lifestyle intervention and insulin treatment should be implemented to improve maternal and neonatal outcomes. This evidence concerns the gene INS and diabetes mellitus.